Deep Brain Stimulation Market Foreseen to Grow Exponentially by 2028

Deep brain stimulation (DBS) refers to a device used for the purpose of providing electrical incitement to some areas of the brain to control the movement. They are extensively utilized to treat diseases such as Parkinson's disease, chronic pain, central pain syndrome, epilepsy and obsessive compulsive disorder among others. Deep brain stimulation involves the surgery for implanting a device that sends a signal to brain areas responsible for body movement.

Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100000996/?utm_source=OpenPR&utm_medium=10357

Leading Companies:

Abbott (St. Jude Medical)
Medtronic
Boston Scientific Corporation
Aleva Neurotherapeutics S.A.
Nexstim
LivaNova PLC
Neuropace Inc.
Cyberonics, Inc.
Nevro Corp.
NeuroSigma, Inc.

IMPACT OF COVID-19 ON DEEP BRAIN STIMULATION MARKET

Public health guidelines of various countries have recommended that elective medical procedures, including deep brain stimulation (DBS) surgery for Parkinson's disease (PD), should not be scheduled during the coronavirus (COVID-19) pandemic to prevent further virus spread and overload on health care systems. However, rescheduling and delaying DBS surgery for patients who suffer from advanced and medication-refractory PD may not be in the best interest of individual patients. Moreover, restricted availability of medical resources, prioritizing some elective and time-sensitive therapeutic procedures may affect the market growth to some extent. As the vaccination progress and spread of virus is set under control procedures like DBS may increase adoption rate which is expected to offer some opportunities to the market.

Growth Drivers:

- The Increasing number of patients suffering from involuntary movements associated with Parkinson's disease, dystonia, and multiple sclerosis.
- Increasing demand for minimally invasive techniques due to enhanced patient outcomes
- Growing awareness about the massive neurological disease burden has raised the demand for deep brain stimulators as an alternative therapy.

Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPHE100000996/?utm_source=OpenPR&utm_medium=10357

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.